GPCRs Revisited: New Insights Lead to Novel Drugs
AbstractGPCRs play a critical role in human physiology and are a prime target for drug discovery globally. Novel insights into the functions of GPCRs are providing unique approaches to modulate these proteins to generate unique drug candidates. Next generation ligands include those with novel pharmacologies such as allosteric regulators as well pepducins, that affect the interaction of GPCRs with G proteins, to either block selective receptor signaling pathways or mimic the actions of intracellular domains of receptors, thereby activating GPCRs to signal selectively to intracellular pathways. We will review these new concepts and then discuss how they may be exploited using modern discovery technologies to provide novel drug candidates for the future.
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Eglen, R.M.; Reisine, T. GPCRs Revisited: New Insights Lead to Novel Drugs. Pharmaceuticals 2011, 4, 244-272.
Eglen RM, Reisine T. GPCRs Revisited: New Insights Lead to Novel Drugs. Pharmaceuticals. 2011; 4(2):244-272.Chicago/Turabian Style
Eglen, Richard M.; Reisine, Terry. 2011. "GPCRs Revisited: New Insights Lead to Novel Drugs." Pharmaceuticals 4, no. 2: 244-272.